What is the recommended potency of topical steroids for treating skin conditions like eczema or psoriasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Topical Steroid Potency Recommendations for Eczema and Psoriasis

For treating skin conditions like eczema and psoriasis, potent to very potent topical corticosteroids are most effective for psoriasis, while mild to medium potency corticosteroids are recommended for eczema, with potency selection based on body location, severity, and treatment duration. 1, 2

Potency Selection Guidelines

For Psoriasis:

  • Potent (Class 2) to Very Potent (Class 1) corticosteroids: Most effective for psoriasis with efficacy rates of 58-92% 1
  • Treatment duration: Limited to 2-4 weeks for Class 1 steroids 1, 3
  • Maximum weekly use: 50g or less for superpotent steroids like clobetasol 3

For Eczema:

  • Mild to Medium potency: First-line for most eczema cases 2
  • Medium potency (e.g., fluticasone 0.05%, mometasone 0.1%): Recommended for itchy lesions on forearms and trunk 2
  • Low potency: Recommended for children, facial areas, and intertriginous zones 2, 4

Body Location Considerations

Body Area Recommended Potency Rationale
Face, genitals, intertriginous areas Low potency or TCIs Thinner skin, higher absorption [2,4]
Trunk, arms, legs Medium to high potency Thicker skin, lower risk of side effects [1,2]
Palms, soles High to very high potency Thickest skin, lower absorption [1]
Scalp Medium to high potency in solution/foam/oil formulations Better penetration through hair [1]

Application Guidelines

  • Frequency: Once or twice daily application 1, 5
  • Duration:
    • Superpotent (Class 1): Maximum 2-3 weeks 3
    • Potent (Class 2): Up to 4 weeks 1
    • Medium potency: Up to 12 weeks 4
    • Low potency: No specified time limit 4
  • Quantity: Use fingertip unit method - one fingertip unit covers approximately 2% body surface area 4

Maintenance Strategy

After achieving control with higher potency steroids, transition to:

  1. Intermittent use of the same potency
  2. Lower potency for continuous use
  3. Non-steroidal alternatives like topical calcineurin inhibitors (especially for facial/intertriginous areas) 2

Common Pitfalls to Avoid

  • Overuse of high-potency steroids: Can lead to skin atrophy, telangiectasia, striae, and HPA axis suppression 1, 6
  • Inadequate potency: Using too low potency for psoriasis can result in treatment failure 1
  • Prolonged continuous use: Increases risk of side effects; use intermittent regimens for maintenance 1, 2
  • Abrupt discontinuation: Can lead to rebound flares; taper treatment when possible 1
  • Inappropriate vehicle selection: Ointments are more potent and better for dry, scaly conditions; creams are better for weeping lesions 4

Special Populations

  • Children: Use lowest effective potency for shortest duration; generally avoid superpotent steroids 2, 4
  • Elderly: Higher risk of skin atrophy; monitor closely 2
  • Pregnant/lactating women: Mild potency steroids are generally safe 2

Treatment Failure Considerations

If no improvement after 2-4 weeks of appropriate topical steroid therapy:

  • Reassess diagnosis
  • Consider alternative treatments (phototherapy, systemic agents)
  • For psoriasis: Consider biologics or methotrexate for moderate-to-severe cases 2, 7

Remember that topical corticosteroids are the cornerstone of treatment for most patients with psoriasis and eczema, but potency selection must balance efficacy with safety considerations.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Eczema Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Topical Corticosteroids: Choice and Application.

American family physician, 2021

Research

Possible side effects of topical steroids.

American family physician, 1981

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.